Verification evidence is still being completed.
PDF / print export
Abera Bioscience
Uppsala, Sweden
- Verified lead
- Maria Alriksson
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Vaccines, Nasal Vaccines, OMV Platforms, Infectious Disease, and Product Development
- Review cycle
- May 2026
- Full address
- Virdings alle 32, 754 50 Uppsala, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Abera Bioscience contact page confirming the Uppsala address.
- Editorial note
- Abera Bioscience is published because official company materials confirm current leadership, Uppsala operating address, and a real Swedish vaccine-development platform.
Vaccines, Nasal Vaccines, OMV Platforms, Infectious Disease, and Product Development
Official leadership disclosure, Official Uppsala address disclosure, Vaccine platform claim
Abera Bioscience is published because official company materials confirm current leadership, Uppsala operating address, and a real Swedish vaccine-development platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Uppsala, Sweden
Abera Bioscience
Vaccines, Nasal Vaccines, OMV Platforms, Infectious Disease, and Product Development · Development-stage vaccine platform
Abera Bioscience runs vaccine platform development, nasal vaccine programs, and laboratory-based product development in Uppsala, Sweden.
- Lead
- Maria Alriksson (verified ↗)
- Address
- Virdings alle 32, 754 50 Uppsala, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Development-stage vaccine platform
- Capabilities
- Vaccine Platform Development · Nasal Vaccine Programs · Laboratory-Based Product Development
- Founded
- 2008
- Headcount
- 1-10
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Maria Alriksson
CEO
Full addressVirdings alle 32, 754 50 Uppsala, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Development-stage vaccine platform
Uppsala, Sweden. Vaccines, Nasal Vaccines, OMV Platforms, Infectious Disease, and Product Development. Review completed on 21 Mar 2026.
Swedish corporate and vaccine-development oversight
Official leadership disclosure, Official Uppsala address disclosure, Vaccine platform claim
Vaccines, Nasal Vaccines, OMV Platforms, Infectious Disease, and Product Development
Abera Bioscience is published because official company materials confirm current leadership, Uppsala operating address, and a real Swedish vaccine-development platform.
Editorial note
Abera Bioscience is published because official company materials confirm current leadership, Uppsala operating address, and a real Swedish vaccine-development platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Vaccine Platform Development
Nasal Vaccine Programs
Laboratory-Based Product Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Vaccine development laboratory
Analytical capacity
Product development infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Abera Bioscience located?
- Abera Bioscience operates from Virdings alle 32, 754 50 Uppsala, Sweden, Uppsala, Sweden.
- Who runs Abera Bioscience?
- Abera Bioscience is led by Maria Alriksson, CEO. Verified 21 Mar 2026.
- What does Abera Bioscience do?
- Abera Bioscience runs vaccine platform development, nasal vaccine programs, and laboratory-based product development in Uppsala, Sweden. Core capabilities: Vaccine Platform Development, Nasal Vaccine Programs, Laboratory-Based Product Development.
Editorial context
Related technical briefs
Briefs that name Uppsala as a covered market or city.